stars 1 stars 2 stars 3

You need to run a preclinical proof-of-concept study in our field of expertise — but you don’t have the in-house know-how or the resources to make it happen. With 25+ years of experience, 200+ studies conducted, and 4 IND-enabling programs completed in the past 4 years, Pelvipharm helps pharmaceutical and biotech companies demonstrate the efficacy of their drug candidates using the most relevant translational preclinical models. If your program targets functional urology, sexual medicine, or women’s health, we can support you from concept to data-driven decisions — efficiently and confidentially. 👉 Reach out today and book a meeting ! (First come, first served basis.)

PELVIPHARM Questions

The PELVIPHARM annual revenue was $5 million in 2026.

Delphine Behr-Roussel is the CEO and CSO of PELVIPHARM.

9 people are employed at PELVIPHARM.

PELVIPHARM is based in Montigny-le-Bretonneux, Île-de-France.

The NAICS codes for PELVIPHARM are [541, 54171, 541713, 5417, 54].

The SIC codes for PELVIPHARM are [873, 87].

Top PELVIPHARM Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users